Interestingly, cisplatin, a chemically similar chemotherapeutic drug also used to treat CRC induces inflammation that enhances TNF-mediated angiogenesis, metastasis and failure of therapy [230]. The gene discussed is TNF; the disease is colorectal carcinoma.